retatrutide phase 2 results 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending There's a lot of excitement

31% of GLP-1 users drank less alcohol in the past year

Updated for 2026 with CMS-0057-F rule, Medicare GLP-1 Bridge program, MFN pricing deals, oral Wegovy approval, and AHIP reform pledges.

Healthy appetite control

What you'll get: an initial provider review and/or telehealth visit (depending on your state of residence), prescription medication (if approved), and prescriber access for questions, concerns, and mandatory 3-month provider check-ins

Exciting updates in the world of GLP-1s

GLP-1 peptide guide for Australia: receptor mechanism, single vs multi-target research compounds, Retatrutide, and the distinction from GH-axis and mitochondrial peptides.